Somatropin HGH is a synthetic form of human growth hormone (HGH) developed using recombinant DNA technology. It is medically prescribed to treat specific growth-related and hormonal conditions in children and adults. Naturally produced by the pituitary gland, growth hormone plays an important role in childhood development, tissue repair, protein metabolism and the regulation of body composition. Understanding its medical applications, potential benefits, limitations and health risks is essential before considering treatment.
What Is Somatropin and How Does It Work?
Somatropin is a laboratory-produced version of naturally occurring human growth hormone. It belongs to a group of medicines called recombinant human growth hormones.
The hormone works by binding to growth hormone receptors in different tissues. It also stimulates the liver and other tissues to produce insulin-like growth factor 1 (IGF-1), which contributes to bone growth, muscle development and cellular functions.
Its primary biological functions include:
- Supporting normal bone development and growth.
- Promoting protein synthesis.
- Supporting lean body tissue development.
- Regulating fat metabolism.
- Influencing glucose metabolism.
- Supporting tissue maintenance and repair.
Growth hormone production naturally changes throughout life, with higher secretion during childhood and adolescence and a gradual decline during adulthood.
Medical Uses and Approved Indications
This medication is prescribed for specific medical conditions following appropriate clinical evaluation. Depending on the approved formulation and country-specific regulations, medical indications may include:
1. Growth Hormone Deficiency in Children
Children with insufficient natural growth hormone production may experience reduced growth velocity and significantly shorter stature. Treatment may help improve linear growth when started before the growth plates close.
2. Growth Hormone Deficiency in Adults
Adults with confirmed hormonal deficiency may experience increased body fat, reduced muscle mass, lower bone density and changes in physical well-being. Replacement treatment may help address certain symptoms.
3. Turner Syndrome
Some girls with Turner syndrome experience significant growth impairment. Hormone treatment may be prescribed to improve height outcomes.
4. Prader-Willi Syndrome
In selected children with this genetic condition, treatment may improve growth and body composition. Careful screening is necessary because respiratory complications can increase treatment risks.
5. Children Born Small for Gestational Age
Children who fail to demonstrate adequate catch-up growth after birth may qualify for treatment following specialist assessment.
Other approved indications can include selected cases of idiopathic short stature and short bowel syndrome, depending on the formulation and jurisdiction.
Current Research and Medical Statistics
Growth hormone deficiency is considered an uncommon endocrine disorder, although its prevalence varies across populations and diagnostic criteria.
A 2025 study published in Advances in Therapy estimated adult growth hormone deficiency prevalence in the United States at between 0.2 and 37 cases per 100,000 people, depending on whether only confirmed cases or confirmed and potentially at-risk individuals were included.
The study also found that only 9.7% of individuals with confirmed deficiency received hormone treatment during the study period. These findings highlight challenges associated with diagnosis and treatment access.
A systematic review of childhood growth hormone deficiency reported prevalence estimates ranging from approximately 1 in 1,107 to 1 in 8,646 across the included studies. Differences in diagnostic methods and population characteristics contributed to this variation.
Sources: Advances in Therapy, 2025; systematic review published in 2024.
How Is Treatment Administered?
Treatment is generally administered through subcutaneous injection, meaning the medicine is delivered beneath the skin.
The injection may be given using an appropriate medical delivery device. Healthcare professionals determine the treatment schedule and dosage according to the patient's age, diagnosis, body weight, clinical response and IGF-1 levels.
Important administration considerations include:
- Following the prescribed treatment schedule.
- Rotating injection sites to reduce local tissue changes.
- Maintaining proper injection hygiene.
- Following recommended storage instructions.
- Avoiding the use of damaged or improperly stored medication.
- Attending regular medical follow-up appointments.
Treatment should never be initiated or adjusted without medical supervision.
Possible Side Effects and Health Risks
Although medically useful for appropriate patients, hormone treatment can cause adverse effects.
Commonly reported side effects include:
- Joint and muscle discomfort.
- Swelling in the hands and feet.
- Headaches.
- Injection-site reactions.
- Muscle stiffness.
- Fluid retention.
More serious complications may include increased intracranial pressure, impaired glucose tolerance, diabetes, nerve compression and worsening of existing medical conditions.
In children, treatment may also be associated with slipped capital femoral epiphysis, a hip growth-plate complication.
People with active malignancy, certain serious illnesses or specific contraindications require particular caution. Regular clinical monitoring is important throughout treatment.
Who Should Avoid Unsupervised Use?
This medication is not appropriate for everyone. Individuals with active cancer, acute critical illness or certain other medical conditions may be unsuitable candidates.
It is also important to understand that growth hormone is not an established treatment for ordinary ageing, cosmetic enhancement, bodybuilding or athletic performance.
The US Food and Drug Administration has specifically warned against unapproved uses promoted for anti-ageing and muscle-building purposes. Such applications can expose individuals to significant health risks without established clinical benefits.
Medical Tests and Monitoring
Before treatment, an endocrinologist may recommend several investigations to establish the diagnosis and evaluate overall health.
These may include:
- IGF-1 blood testing.
- Growth hormone stimulation testing.
- Thyroid function tests.
- Blood glucose and HbA1c measurements.
- Assessment of bone age in children.
- Evaluation of pituitary function.
- Additional imaging when clinically indicated.
Monitoring may continue throughout treatment to assess effectiveness, hormone levels, metabolic changes and potential adverse effects.
Conclusion
Somatropin is an important medical treatment for selected growth-related and endocrine disorders. Its therapeutic value depends on an accurate diagnosis, appropriate patient selection and continuous medical supervision. Although it can improve growth outcomes and address certain consequences of hormone deficiency, inappropriate use may lead to serious complications. Understanding its indications, limitations, side effects and monitoring requirements helps patients make informed decisions in consultation with qualified healthcare professionals.